{"transactions":[{"id":2050562,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-01-19T16:30:27.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":5712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 5,712 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 5,712 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."}],"balance_after":19761,"source":{"system":"sec-edgar","filing":"0001493152-23-001918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315223001918/ownership.xml","form_type":"4"}},{"id":2106706,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-11-22T16:03:15.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":666,"price":1.334,"value":888.444,"ownership":{"direct":true},"balance_after":14019,"source":{"system":"sec-edgar","filing":"0001493152-22-033340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222033340/ownership.xml","form_type":"4"}},{"id":2106705,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-11-22T16:03:15.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":99,"price":1.3401,"value":132.6699,"ownership":{"direct":true},"balance_after":14685,"source":{"system":"sec-edgar","filing":"0001493152-22-033340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222033340/ownership.xml","form_type":"4"}},{"id":2134503,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-10-19T09:00:32.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":10841,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 10,841 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 10,841 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":73920,"source":{"system":"sec-edgar","filing":"0001493152-22-028717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222028717/ownership.xml","form_type":"4"}},{"id":2200036,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-07-29T16:59:15.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":6141,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 6,141 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 6,141 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":63079,"source":{"system":"sec-edgar","filing":"0001493152-22-020760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222020760/ownership.xml","form_type":"4"}},{"id":2294571,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-19T19:36:56.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":5157,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 5,157 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 5,157 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":56938,"source":{"system":"sec-edgar","filing":"0001493152-22-010475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222010475/ownership.xml","form_type":"4"}},{"id":2310877,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-01T16:30:23.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":43478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":51781,"source":{"system":"sec-edgar","filing":"0001493152-22-008829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222008829/ownership.xml","form_type":"4"}},{"id":2429971,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-01-20T21:23:45.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":4055,"price":1.31,"value":5312.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 18, 2022, the Reporting Person was granted 4,055 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":8303,"source":{"system":"sec-edgar","filing":"0001493152-22-001793","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222001793/ownership.xml","form_type":"4"}},{"id":2763502,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-01T21:27:22.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":13015,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13015,"derivative":{"exercise_price":4.61,"exercise_date":"2021-03-30","expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":13015},"source":{"system":"sec-edgar","filing":"0001493152-21-007811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315221007811/ownership.xml","form_type":"4"}},{"id":3434142,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-19T16:18:14.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly in twelve equal installments beginning on August 23, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.15,"exercise_date":"2019-08-23","expiration_date":"2029-07-23","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-19-000704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000090571819000704/ownership.xml","form_type":"4"}},{"id":3458965,"issuer":{"id":155932,"kind":"organization","name":"Telemynd, Inc.","symbol":"NONE"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T18:47:10.000Z","date":"2019-07-16","kind":"other","acquired":true,"shares":97110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."}],"balance_after":97110,"source":{"system":"sec-edgar","filing":"0001213900-19-013141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611395/000121390019013141/ownership.xml","form_type":"4"}},{"id":3694416,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-01-16T16:47:55.000Z","date":"2019-01-14","kind":"purchase","acquired":true,"shares":100000,"price":0.225,"value":22500.0,"ownership":{"direct":true},"balance_after":127500,"source":{"system":"sec-edgar","filing":"0000905718-19-000057","document":"cancer_fm4jan142019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000090571819000057/cancer_fm4jan142019.xml","form_type":"4"}},{"id":3793778,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-10-11T00:04:48.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":45000,"price":1.38,"value":62100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The above restricted shares were granted under Mynd Analytics, Inc.'s (the \"Company\") Amended and Restated 2012 Omnibus Incentive Compensation Plan and vest quarterly."}],"balance_after":97110,"source":{"system":"sec-edgar","filing":"0001615774-18-010689","document":"s113207_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010689/s113207_form4.xml","form_type":"4"}},{"id":4139700,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T21:06:16.000Z","date":"2017-12-06","kind":"purchase","acquired":true,"shares":3500,"price":3.8,"value":13300.0,"ownership":{"direct":true},"balance_after":52110,"source":{"system":"sec-edgar","filing":"0001615774-17-007195","document":"s108370_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417007195/s108370_form4.xml","form_type":"4"}},{"id":4139699,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T21:06:16.000Z","date":"2017-12-06","kind":"purchase","acquired":true,"shares":1000,"price":3.85,"value":3850.0,"ownership":{"direct":true},"balance_after":48610,"source":{"system":"sec-edgar","filing":"0001615774-17-007195","document":"s108370_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417007195/s108370_form4.xml","form_type":"4"}},{"id":4139698,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T21:06:16.000Z","date":"2017-12-05","kind":"purchase","acquired":true,"shares":52,"price":3.6,"value":187.2,"ownership":{"direct":true},"balance_after":47610,"source":{"system":"sec-edgar","filing":"0001615774-17-007195","document":"s108370_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417007195/s108370_form4.xml","form_type":"4"}},{"id":4197448,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-02T17:03:40.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":5000,"derivative":{"exercise_price":2.75,"exercise_date":"2018-09-28","expiration_date":"2027-09-28","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001349929-17-000077","document":"wf-form4_150697820661484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992917000077/wf-form4_150697820661484.xml","form_type":"4"}},{"id":4197447,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-10-02T17:03:40.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":27500,"source":{"system":"sec-edgar","filing":"0001349929-17-000077","document":"wf-form4_150697820661484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992917000077/wf-form4_150697820661484.xml","form_type":"4"}},{"id":4204432,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-09-21T19:57:02.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments beginning on December 19, 2017."}],"balance_after":18000,"derivative":{"exercise_price":3.6,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001615774-17-005240","document":"s107566_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005240/s107566_form4.xml","form_type":"4"}},{"id":4204431,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-21T19:57:02.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":47558,"source":{"system":"sec-edgar","filing":"0001615774-17-005240","document":"s107566_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005240/s107566_form4.xml","form_type":"4"}},{"id":4288100,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T16:36:50.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":10000,"derivative":{"exercise_price":4.15,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-17-000051","document":"wf-form4_149695419441783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992917000051/wf-form4_149695419441783.xml","form_type":"4"}},{"id":4288099,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-06-08T16:36:50.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001349929-17-000051","document":"wf-form4_149695419441783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992917000051/wf-form4_149695419441783.xml","form_type":"4"}},{"id":4317861,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-05-16T16:41:05.000Z","date":"2017-05-16","kind":"purchase","acquired":true,"shares":2500,"price":3.75,"value":9375.0,"ownership":{"direct":true},"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001349929-17-000033","document":"wf-form4_149496724738548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992917000033/wf-form4_149496724738548.xml","form_type":"4"}},{"id":4407015,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-04T00:05:30.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":5000,"price":6.25,"value":31250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."}],"balance_after":29558,"source":{"system":"sec-edgar","filing":"0001615774-17-000892","document":"s105482_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417000892/s105482_form4.xml","form_type":"4"}},{"id":4521884,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-12-14T16:06:21.000Z","date":"2016-12-14","kind":"purchase","acquired":true,"shares":2500,"price":1.5,"value":3750.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001349929-16-000136","document":"wf-form4_148174956163478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992916000136/wf-form4_148174956163478.xml","form_type":"4"}},{"id":4552536,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-11-16T16:09:00.000Z","date":"2016-11-14","kind":"purchase","acquired":true,"shares":5000,"price":1.55,"value":7750.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001349929-16-000132","document":"wf-form4_147933052048672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992916000132/wf-form4_147933052048672.xml","form_type":"4"}},{"id":4570144,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T01:13:53.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The award was recommended by the compensation committee and approved by the board of directors of MYnd Analytics, Inc. (the \"Registrant\") on September 22, 2016, subject to stockholder approval of the Amended and Restated 2012 Omnibus Incentive Compensation Plan (the \"Plan\") under which the award was granted. The Registrant's stockholders approved the Plan on November 1, 2016."}],"balance_after":24558,"source":{"system":"sec-edgar","filing":"0001615774-16-007985","document":"s104521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007985/s104521.xml","form_type":"4"}},{"id":4579988,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-13T16:29:37.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":10000,"derivative":{"exercise_price":1.81,"exercise_date":"2017-10-11","expiration_date":"2026-10-11","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-16-000117","document":"wf-form4_147639056477757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992916000117/wf-form4_147639056477757.xml","form_type":"4"}},{"id":4579987,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-10-13T16:29:37.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001349929-16-000117","document":"wf-form4_147639056477757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000134992916000117/wf-form4_147639056477757.xml","form_type":"4"}},{"id":4596749,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2016-09-23T22:06:23.000Z","date":"2016-09-21","kind":"disposition_to_issuer","acquired":false,"reported_value":10000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Stock Warrant was exercisable as of its date of issuance."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001615774-16-007354","document":"s104196_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007354/s104196_form4.xml","form_type":"4"}},{"id":4596748,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"5% Secured Convertible Note due December 2017","published_at":"2016-09-23T22:06:23.000Z","date":"2016-09-21","kind":"exercise","acquired":false,"reported_value":10000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"One note in the aggregate principal amount of $10,000 was purchased by the Reporting Person on February 23, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. This note was convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $10,000 in aggregate principal amount of the Reporting Person's note, with accrued interest thereon of $286.30, at a conversion price of $5.00 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"One note in the aggregate principal amount of $10,000 was purchased by the Reporting Person on February 23, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. This note was convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $10,000 in aggregate principal amount of the Reporting Person's note, with accrued interest thereon of $286.30, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One note in the aggregate principal amount of $10,000 was purchased by the Reporting Person on February 23, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. This note was convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $10,000 in aggregate principal amount of the Reporting Person's note, with accrued interest thereon of $286.30, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"One note in the aggregate principal amount of $10,000 was purchased by the Reporting Person on February 23, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. This note was convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $10,000 in aggregate principal amount of the Reporting Person's note, with accrued interest thereon of $286.30, at a conversion price of $5.00 per share of common stock."}],"derivative":{"exercise_price":5,"exercise_date":"2016-09-01","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":2058},"source":{"system":"sec-edgar","filing":"0001615774-16-007354","document":"s104196_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007354/s104196_form4.xml","form_type":"4"}},{"id":4596747,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120600,"kind":"person","name":"Harris Geoffrey E.","position":1,"cik":"0001611395","reported_name":"Harris Geoffrey E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T22:06:23.000Z","date":"2016-09-21","kind":"exercise","acquired":true,"shares":2058,"price":5,"value":10290.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."}],"balance_after":4558,"source":{"system":"sec-edgar","filing":"0001615774-16-007354","document":"s104196_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007354/s104196_form4.xml","form_type":"4"}}]}